首页> 外文期刊>Papillomavirus Research >Letter-to-the-Editor in response to “Tanton C, et al. Human papillomavirus (HPV) in young women in Britain: Population-based evidence ofthe effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types. Papillomavirus Res. 2017 Jun;3:36-41.doi: 10.1016/j.pvr.2017.01.001.”
【24h】

Letter-to-the-Editor in response to “Tanton C, et al. Human papillomavirus (HPV) in young women in Britain: Population-based evidence ofthe effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types. Papillomavirus Res. 2017 Jun;3:36-41.doi: 10.1016/j.pvr.2017.01.001.”

机译:写给编辑的信,回应“ Tanton C等人。英国年轻女性中的人乳头瘤病毒(HPV):基于人群的二价免疫计划有效性以及四价和9价疫苗类型负担的证据。乳头瘤病毒Res。 2017年6月; 3:36-41.doi:10.1016 / j.pvr.2017.01.001。”

获取原文
           

摘要

Samples in Natsal-2 were collected in a urine collection cup, whereas samples in Natsal-3 were collected with a specific device (Firstburst) that collects the first-void urine. It has been shown that Chlamydia organism load is 6 times higher in the Firstburst collected first-void urine compared to urine collected in a regular cup [3]. As the use of different collection techniques may impact the HPV load, we wish to understand whether a validation of the Firstburst versus the urine cup sample collection has been conducted prior to the analysis.
机译:Natsal-2中的样品收集在尿液收集杯中,而Natsal-3中的样品使用特定设备(Firstburst)收集,该设备可收集初次排尿。研究表明,与常规杯中收集的尿液相比,Firstburst收集的第一空尿中的衣原体生物量高出6倍[3]。由于使用不同的采集技术可能会影响HPV负荷,因此我们希望了解在分析之前是否已对Firstburst和尿杯样品采集进行了验证。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号